Dairy Farm International's 1H21 underlying profit of US$32.1m (-81% h-o-h, -69% y-o-y) disappointed. Key drags were
lower government grants, and
weaker associate earnings.
Dairy Farm International's 2H21F likely to remain challenging with
lack of Chinese tourist arrivals in HK, and
ongoing Covid-related movement restrictions in Southeast Asia.
We lower expectations on pace of margin recovery as Dairy Farm International undertakes more price investment campaigns. Downgrade Dairy Farm International to HOLD and lower target price to US$4.00.
Dairy Farm International Reported Weak 1H21 Performance
Dairy Farm International (SGX:D01)’s 1H21 underlying profit of US$32.1m (-81% h-o-h, -69% y-o-y) disappointed at 11%/10% of our/consensus FY21F. Key surprise was weaker than expected topline (- 13% y-o-y), as Dairy Farm International remains significantly affected by the ongoing pandemic. Convenience store segment was the exception with revenue growth on a y-o-y basis while other key segments saw declines.
Operating deleverage and lower government grants caused lower underlying operating profit of US$155m (-27% y-o-y). Dairy Farm International was also hurt by weaker contribution from associates and joint ventures (US$43.6m loss in 1H21 vs US$4.4m profit in 1H20).
An interim dividend of US$0.03 per share (-40% y-o-y) was declared.
Transformation Taking Shape, But Earnings Recovery Will Take Time
2H21F should remain challenging; we forecast Dairy Farm International’s core net profit to fall 8% y-o-y.
Health and Beauty cut Dairy Farm International's FY21-23F earnings per share forecasts by 0.6-36.0%.
Home Furnishing Segment a Focus in FY21/22F
Dairy Farm announced in May 21 that it will be exiting its Giant banner in Indonesia productivity and margin of this segment.
Downgrade Dairy Farm HOLD With a Lower Target Price of US$4.00
We downgrade Dairy Farm International from Add to HOLD, in view of the near-term challenging 22x previously.
We will turn more positive on
HK-China border reopening allowing quarantine-free travel, or
stronger margin expansion.
Downside risks: slow resolution of COVID-19, intensifying competition from e-commerce.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....